News

Soleno Therapeutics Faces Scrutiny: Dive into Recent Stock Decline

Soleno Therapeutics Faces Scrutiny: Dive into Recent Stock Decline

Soleno Therapeutics Under Pressure Following Critical Report

Recently, shares of Soleno Therapeutics, Inc. (NASDAQ: SLNO) have seen a notable decline. This downturn follows the release of a critical report that has uncovered troubling information about the company's practices. Investors are now left questioning the validity of Soleno's claims regarding its product VYKAT™ XR.

Understanding the Investigation by Hagens Berman

Hagens Berman, a well-regarded firm representing shareholders, has initiated an inquiry into Soleno Therapeutics. The case aims to ascertain whether the company misled its investors about the safety and market potential of its drug, VYKAT™ XR. This oral medication is aimed at treating hyperphagia, a difficult condition associated with Prader-Willi syndrome, which significantly affects patients and their families.

The Importance of VYKAT™ XR in the Market

VYKAT™ XR has been marketed as a crucial treatment for hyperphagia, which is considered one of the most challenging aspects of Prader-Willi syndrome, a rare genetic disorder that has a substantial impact on individuals’ physical and mental health. Soleno's claims about the drug drew interest from investors, as its successful launch could potentially lead to significant financial returns.

Concerns from the Critical Report

However, the recent report highlights alarming findings. It notes that there has been an increase in hospitalizations of children who have used VYKAT™ XR, raising red flags about its safety. This has led some analysts to speculate that the drug might face a withdrawal from the market or experience a severe drop in prescriptions.

What the Report Reveals About Soleno Therapeutics

Further highlighting its severe position, the report characterized Soleno as a "one-trick pony," suggesting that without VYKAT™ XR, the company lacks a viable asset. Moreover, the report emphasizes concerns about the integrity of the research underpinning VYKAT™ XR, implying that some of the studies may not meet scientific standards.

Potential Consequences for Investors

As the investigation unfolds, investors who have suffered losses may wish to share their experiences, which could aid in understanding the overall impact of these allegations. Hagens Berman is committed to protecting investors' rights and ensuring that those potentially harmed by misleading information can pursue justice.

Reed Kathrein, a partner at Hagens Berman, expressed the firm’s intent to determine whether Soleno misled its investors regarding VYKAT™ XR's commercial viability. He emphasized that understanding the truth behind these claims is vital for current and potential shareholders.

Looking Ahead: What’s Next for Soleno Therapeutics?

In the wake of these developments, the future of Soleno Therapeutics remains uncertain. Investors are keenly observing the company's next moves and any updates regarding VYKAT™ XR’s performance in both the market and clinical settings. As more information becomes available, the dialogue surrounding Soleno Therapeutics will inevitably intensify.

The Role of Whistleblowers

Additionally, the potential for whistleblowers to come forward regarding internal practices or information becomes crucial during this time. Those possessing knowledge about the operations of Soleno Therapeutics are encouraged to reach out, whether for the benefit of the investigation or to explore the SEC Whistleblower program. This initiative offers rewards to individuals who provide significant information that aids in recovering losses.

Frequently Asked Questions

What caused the drop in Soleno Therapeutics' stock price?

The drop was primarily due to a critical report by Scorpion Capital questioning the safety and efficacy of VYKAT™ XR, along with an investigation initiated by Hagens Berman.

What is VYKAT™ XR used for?

VYKAT™ XR is intended to treat hyperphagia, which is a condition linked with Prader-Willi syndrome. This condition poses various physical and behavioral challenges for those affected.

How has Hagens Berman responded to the report?

The firm has started an investigation into Soleno Therapeutics to determine if they misled investors in their statements regarding VYKAT™ XR's commercial prospects.

What risks does Soleno face moving forward?

Soleno may face significant risks, including potential market withdrawal of VYKAT™ XR and loss of investor confidence due to the findings of the report and ongoing investigations.

Should investors be concerned about their investments in SLNO?

Yes, investors should closely monitor developments regarding the investigation and the subsequent impact on the company's reputation and share value as new information comes to light.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

J. Harmon Tests a Smarter Cannabis Accessory Niche

Updated Category News Views 138

Aisle Space Is the Real Prize Most cannabis accessory launches arrive dressed up like a gimmick and disappear before anyone has reordered them. J. Harmon has a more sensible target: give women products that look deliberate, work in everyday routines and do not demand designer-level money. The brand is set to debut at MJBizCon 2026 in Las Vegas, with LUVBUDS handling...

Continue Reading
Dario's Personify Panel Puts Distribution Model in Focus

Updated Category News Views 170

A Partner Megaphone Is Not a Revenue Line Monday's virtual panel gives DarioHealth a useful stage, but investors should not confuse a conference microphone with a signed sales order. Erez Raphael is set to lead a November 23 discussion with Personify Health President Ed Liebowitz at the U.S. Bancorp | BTIG Tech-Enabled Healthcare Forum, running from noon to 12:50 p.m....

Continue Reading
Straub's Court Win Raises Cost of Seven-Year Fight

Updated Category News Views 0

Seven years of courtroom smoke over an under-$80,000 lien is the sort of mess that makes any business owner grind his teeth. Palm Beach Polo says its president, Glenn Straub, has again prevailed against Jessica Nicodemo in Palm Beach County, following an earlier Broward County dismissal of related claims. The company also says Vice President Sal Spano received a directed...

Continue Reading
Thanksgiving Kitchen Safety Is No Place for Autopilot

Updated Category News Views 126

Steam, chatter, and one forgotten burner can turn a holiday meal ugly in a hurry. The Consumer Product Safety Commission’s Nov. 19, 2026 reminder lands on a point that should not need repeating, yet plainly does: Thanksgiving kitchens demand attention, not casual optimism. This is not about ruining anybody’s celebration with a lecture. It is about recognizing that a...

Continue Reading
Prospera’s DFW Culture Win Matters Beyond the Plaque

Updated Category News Views 46

Employee survey ballots rarely make pulses race, but this one deserves more than a lazy shrug. Prospera Financial Services has landed on The Dallas Morning News’ 2026 Top Workplaces DFW list for a second consecutive year, placing in the Top Small Workplaces category. For a boutique independent broker-dealer, that is not meaningless wall décor. The people doing the...

Continue Reading
PayPal's New Leadership Map Puts Execution on Trial

Updated Category News Views 70

Four senior appointments and a risk-chief exit can turn a tidy strategy slide into a very real operating test. PayPal has spent months defining three-year plans, simplifying its operating model and assigning clearer accountability; on November 20, it put names beside the jobs. For NASDAQ:PYPL investors, that is more consequential than another broad promise about...

Continue Reading
Corner Bakery Bets on Holiday Catering Convenience

Updated Category News Views 150

A $50 carrot on a $350 catering tab tells you exactly where Corner Bakery sees the holiday battlefield: not in one lonely cookie sale, but in the larger group order that can make a restaurant’s day. The chain is pushing holiday catering through November and December, pairing that discount with bakery trays, meals for groups and a promise to handle delivery setup. It is...

Continue Reading
Minnesota Giving Record Signals a Stressed Safety Net

Updated Category News Views 25

Thirty-eight million dollars landing in one day is no small civic heartbeat. Minnesota’s Give to the Max Day brought in a record $38.4 million in 2026 for nearly 6,000 nonprofits and schools, edging past the $37.8 million raised in 2025. More than 65,000 people gave. That deserves a clear-eyed nod, not a cynical shrug. Still, the number carries two messages at once. It...

Continue Reading
1031 Specialists Takes Tax Deferral to Public TV

Updated Category News Views 50

A tax rule most people ignore is getting a television spotlight. 1031 Specialists says it will appear on All Access with Andy Garcia, an educational series distributed to Public Television stations nationwide, to explain the 1031 exchange and its role in real estate investing. That is a sensible bit of exposure for a niche business built around a topic investors tend to...

Continue Reading
TD Pledges $2 Billion to Financial Strength by 2036

Updated Category News Views 102

A Longer-Term Bet on Household Resilience A bank’s community budget rarely grabs the market by the collar, but TD’s new target deserves more than a polite nod. The bank says it will direct $2 billion, or US$1.4 billion, toward helping people build financial strength across North America over the next decade. That is a sizable commitment, even for an institution with...

Continue Reading

Top 5 Most Recently Viewed Articles

European Wax Center's Inducement Grants for New Executives

Updated Category News Views 140

Overview of Inducement Grants European Wax Center, Inc. (NASDAQ: EWCZ), known as a leading provider of out-of-home waxing services across the United States, has recently made headlines with its strategic inducement grants. This move comes in light of the recent appointments of key executives, aiming to bolster the company's leadership and operational capabilities....

Continue Reading
Enhancing AI Security: Check Point and Microsoft Partnership

Updated Category News Views 283

Enhancing AI Security Through Strategic Collaboration Check Point Software Technologies Ltd. (NASDAQ: CHKP), a renowned global leader in cyber security solutions, has embarked on an exciting partnership with Microsoft. This collaboration aims to inject enterprise-grade AI security into the Microsoft Copilot Studio, ensuring that organizations can innovate safely and...

Continue Reading
TransMontaigne Partners Strengthen Credit Facility with Extension

Updated Category News Views 238

TransMontaigne Partners LLC Enhances Credit Facility Terms TransMontaigne Partners LLC has recently announced a significant development in its financial strategy. The company has officially closed Amendment No. 4 to its existing Credit Agreement, which illustrates its commitment to optimizing financial operations and enhancing financial stability. Understanding the...

Continue Reading
Red Cross Issues Urgent Call for Blood Donations Beyond Holidays

Updated Category News Views 119

Urgent Appeal for Blood Donations Post-Holiday Season The American Red Cross is currently confronting the threat of a significant blood shortage. As the busy holiday season comes to a close, blood donation rates have plummeted. Unfortunately, the rate at which blood products are being distributed now exceeds the number of donations received, raising concerns about the...

Continue Reading
Weight Loss Drugs Linked to Genetic Hair Loss in Men

Updated Category News Views 34

When weight loss turns hairy, it's not just an old wives' tale. We have some solid evidence from those eggheads at NYU Langone Health, who unearthed this hairy connection between popular weight loss drugs and the glinting domes of the genetically predisposed. Understanding the Hair-Drug Connection The name Ozempic might sound familiar, and not just because it's been...

Continue Reading